Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases – a guide for the generalist

John A Snowden, consultant haematologist, director of BMT and chair of the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)^A ⇑,
Basil Sharrack, consultant neurologist^B,
Mohammed Akil, consultant rheumatologist^C,
David G Kiely, consultant respiratory physician^D,
Alan Lobo, consultant gastroenterologist^E,
Majid Kazmi, consultant haematologist^F,
Paolo A Muraro, professor of neurology, neuroimmunology and immunotherapy^G and
James O Lindsay, professor of inflammatory bowel disease^H

^ADepartment of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK
^BDepartment of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK
^CDepartment of Rheumatology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK
^DSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK
^EDepartment of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK
^FKings Healthcare Partners, London, UK
^GBrain Sciences, Imperial College London, London, UK
^HCentre for Immunobiology, Barts and the London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK

Address for correspondence: Professor John Snowden, Sheffield Teaching Hospitals NHS Foundation Trust, Haematology, Royal Hallamshire Hospital, Sheffield S10 2JF, UK. Email: john.snowden{at}sth.nhs.uk

Article usage